PDEX Pro Dex Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PDEX

Price (delayed)

$61.375

Market cap

$195.96M

P/E Ratio

16.59

Dividend/share

N/A

EPS

$3.7

Enterprise value

$205.3M

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 82
Relative Valuation: Rel. Valuation: 79
Relative Profitability: Rel. Profitability: 76

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We ...

Highlights
Pro Dex's EPS has increased by 30% YoY and by 7% QoQ
PDEX's equity is up by 28% year-on-year and by 9% since the previous quarter
The quick ratio is up by 48% year-on-year but it has declined by 5% since the previous quarter
Pro Dex's debt has surged by 77% QoQ
PDEX's P/E is 26% above its last 4 quarters average of 12.6
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.pro-dex.com
Peers: RVP ALGN DHR TMO

Key stats

What are the main financial stats of PDEX

PDEX stock price

How has the Pro Dex stock price performed over time
Intraday
4.79%
1 week
7.19%
1 month
0.07%
1 year
29.62%
YTD
59.5%
QTD
4.82%

Financial performance

How have Pro Dex's revenue and profit performed over time
Revenue
$74.64M
Gross profit
$20.73M
Operating income
$10.81M
Net income
$12M
Gross margin
27.8%
Net margin
16.1%
PDEX's net income is up by 28% year-on-year and by 6% since the previous quarter
PDEX's operating margin is down by 20% YoY and by 8% QoQ
PDEX's revenue is up by 16% YoY and by 3.5% QoQ
The gross margin has declined by 11% year-on-year

Price vs fundamentals

How does PDEX's price correlate with its fundamentals

Growth

What is Pro Dex's growth rate over time

Valuation

What is Pro Dex stock price valuation
PDEX P/E details
P/E
16.59
P/B
4.35
P/S
2.63
EV/EBIT
12.18
EV/EBITDA
11.3
EV/Sales
2.75
Pro Dex's EPS has increased by 30% YoY and by 7% QoQ
PDEX's P/E is 26% above its last 4 quarters average of 12.6
PDEX's price to book (P/B) is 38% higher than its 5-year quarterly average of 3.0 and 26% higher than its last 4 quarters average of 3.3
PDEX's equity is up by 28% year-on-year and by 9% since the previous quarter
The stock's price to sales (P/S) is 48% more than its 5-year quarterly average of 1.7 and 32% more than its last 4 quarters average of 1.9
PDEX's revenue is up by 16% YoY and by 3.5% QoQ

Efficiency

How efficient is Pro Dex business performance
Pro Dex's ROIC has increased by 20% YoY and by 3.7% from the previous quarter
Pro Dex's return on assets has increased by 13% YoY
Pro Dex's return on sales has increased by 10% YoY

Dividends

What is PDEX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PDEX.

Financial health

How did Pro Dex financials performed over time
The total assets is 152% greater than the total liabilities
The quick ratio is up by 48% year-on-year but it has declined by 5% since the previous quarter
PDEX's total liabilities is up by 44% QoQ and by 2.7% YoY
Pro Dex's debt is 57% lower than its equity
Pro Dex's debt has surged by 77% QoQ
Pro Dex's debt to equity has soared by 65% from the previous quarter but it has decreased by 20% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.